Drug Development/R&D- OHE

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Insight
March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

News
June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

Past Event
April 2020

How Should the World Pay for a COVID-19 Vaccine?

News
April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

News
March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

News
March 2020

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

News
February 2020

A Final MVAC Blueprint—and the Start of an R&D Revolution?

News
September 2019

Data Governance Arrangements for Real-world Evidence in Japan

Insight
May 2019

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

News
March 2019

The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback

Latest Research & Publications

The Dynamics of Drug Shortages

2022 OHE Annual Report to the Charity Commission

Capturing the Broader Value of Antibiotics

Innovation for Health System Efficiency and Improvement

Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?

Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective

Reimagining Prevention for a Healthier, More Prosperous Society

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

All Publications

Drug Development Process and R&D

Filter results by

Drug Shortages: What are the causes, consequences and pathways to a solution?

Drug shortages are on the rise – but what is their impact?

Filter results by

Would Waiving COVID-19 Vaccines Patents Save Lives?

Does Government Funding Increase Public Sector Development of New Medicines?

Payment Models for Multi-Indication Therapies

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

How Should the World Pay for a COVID-19 Vaccine?

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

A Final MVAC Blueprint—and the Start of an R&D Revolution?

Data Governance Arrangements for Real-world Evidence in Japan

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback

Share on Mastodon